Online event for anyone interested: Survived cancer – how are you…

DKFZ German Cancer Research Center of the Helmholtz Association

Surviving Cancer – What’s Next? Medical monitoring and psychosocial aspects.

For all those interested, this online event of the Cancer Information Service (DKFZ) will take place on April 28, 2022 from 4 p.m. to 6 p.m. You are always welcome to register.

German Cancer Research Center of the Helmholtz Association

April 21, 2022 (jg)

Surviving Cancer – What’s Next?

An online event in the series “Understandably informed about cancer. Your questions – our answers”, organized by the Cancer Information Service of the German Cancer Research Center

After the initial cancer treatment is complete, rehabilitation and aftercare follow. What does tracking include? This means measures aimed at detecting a relapse at an early stage, treating possible late and long-term consequences, improving the quality of life and stabilizing the psychosocial situation. How long does the follow-up last and what tests does it include? What are the long term effects of cancer? Who is responsible for monitoring and where are there supply gaps? These and other questions are at the center of the event April 28, 2022 from 4 p.m. to 6 p.m. Registration is now possible.

Privatdozent Dr. medical Georgia Schilling, chief physician for oncological rehabilitation at Asklepios Nordseeklinik Westerland GmbH and chief physician at Asklepios Tumor Center Hamburg as well as specialist lecturer for rehabilitation at Semmelweis University, Campus Hamburg and medical Dr. Andrea Penzkofer, head of the knowledge management working group of the Cancer Information Service of the DKFZ in Heidelberg, provides insight and information on specific topics of cancer follow-up.

After the presentations, it will be possible to ask questions to the speakers.

Registration is now possible under the following link:

The program and further information can be found on the website of the Cancer Information Service:

Cancer Knowledge – Your Questions, Our Answers Online Event Series

Cancer Information Service events are aimed at the general public with the aim of providing understandable information on relevant aspects of cancer and exchanging views with affected individuals, their families and interested parties.

Other events are expected from September 2022 to give. If you have any topic suggestions, please send them to [email protected]

With more than 3,000 employees, the German Cancer Research Center (DKFZ) is Germany’s largest biomedical research center. More than 1,300 scientists at DKFZ study how cancer develops, record cancer risk factors and research new strategies to prevent people from developing cancer. They are developing new methods with which tumors can be diagnosed more accurately and cancer patients can be treated more successfully.

At the Cancer Information Service (KID) of the DKFZ, concerned and interested citizens and specialist groups receive individual answers to all questions about cancer.

Together with partners from the university clinics, the DKFZ operates the National Center for Tumor Diseases (NCT) at the sites in Heidelberg and Dresden, and the Hopp Children’s Cancer Center KiTZ in Heidelberg. In the German Consortium for Translational Cancer Research (DKTK), one of six German centers for health research, the DKFZ operates translation centers at seven partner universities. The combination of excellent academic medicine with the cutting-edge research of a Helmholtz Center at the NCT and DKTK sites is an important contribution to the transfer of promising approaches from cancer research to the clinic and thus improves the chances of patients with cancer. The DKFZ is funded 90% by the Federal Ministry of Education and Research and 10% by the Land of Baden-Württemberg and is a member of the Helmholtz Association of German Research Centers.

Contact for the press:

Dr. Sibylle Kohlstädt
Strategische Kommunikation und Öffentlichkeitsarbeit  
Deutsches Krebsforschungszentrum
Im Neuenheimer Feld 280
69120 Heidelberg
T: +49 6221 42 2843
F: +49 6221 42 2968
E-Mail: [email protected]
E-Mail: [email protected]

Leave a Comment